Advances in technology for quality of life implantable devices and rising consumer awareness of diseases such as Parkinson's and Alzheimer's impact this market. Influx of new players is giving rise to increased investments and research and developments with insurance companies wondering about reimbursement activity. The U.S. ranks highest with greater than a 75 percent share to date. Leading players are Boston Scientific Corporation; St. Jude Medical, Inc.; and Northstar Neuroscience, Inc.

Worldwide installed base of CT scanners: +88K units by 2015
Hybrid scanners comprising PET and CT image capabilities are the trend, but a modest growth rate is expected for multi-slice computed tomography scanners. The market is declining for single slice CT scanners where pricing alone seems to determine competition. The U.S., Europe and Japan account for 85 percent. Market leaders are GE, Siemens, Toshiba and Philips.


Chemistry analyzers and reagents: $5.7 billion by 2012
Diagnostic testing influencers are technology and efficiency, related to investments in laboratory equipment for clinical chemistry analyzers and reagents. Protocols must simplify workflow, enhance quality and accuracy, and be automated and user-friendly despite increased volume and early diagnosis demands. The U.S. and Europe hold 71 percent share with Asia-Pacific touted as emerging.

Fluoroscopy and mobile C-arms: +9.6K units by 2012
Growth for this market is crawling but less-so in developing countries. Replacement sales, especially in developed countries comprise the market. Mobile C-arms represent 54 percent of this market as physicians require real-time images of the body internally. Ever-changing technology affects this market where GE Healthcare and Philips Medical Systems are key players.

Global Industry Analysts, Inc., one of the world's largest market research publishers, offers more than 850 off-the-shelf market research reports.

Back to HCB News

More Industry Headlines